No abstract available
MeSH terms
-
Alemtuzumab
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal, Humanized
-
Antibodies, Monoclonal, Murine-Derived
-
Antibodies, Neoplasm / adverse effects
-
Antineoplastic Agents / adverse effects*
-
DNA, Viral / analysis
-
Hepatitis B Core Antigens / analysis
-
Hepatitis B Surface Antigens / analysis
-
Hepatitis B virus / drug effects*
-
Hepatitis B, Chronic* / diagnosis
-
Hepatitis B, Chronic* / drug therapy
-
Hepatitis B, Chronic* / prevention & control
-
Humans
-
Lamivudine / therapeutic use
-
Recurrence
-
Risk Factors
-
Rituximab
-
Virus Activation / drug effects
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antibodies, Monoclonal, Murine-Derived
-
Antibodies, Neoplasm
-
Antineoplastic Agents
-
DNA, Viral
-
Hepatitis B Core Antigens
-
Hepatitis B Surface Antigens
-
Lamivudine
-
Alemtuzumab
-
Rituximab